Firdous Ahmad Bhat

Firdous Ahmad Bhat

Auto-generated profile, based on publicly available information

Firdous Ahmad Bhat

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
DMDong-Gi Mun
Dong-Gi Mun
FBFirdous A. Bhat
Firdous A. Bhat
NJNeha Joshi
Neha Joshi
LSLeticia Sandoval
Leticia Sandoval
HDHusheng Ding
Husheng Ding
APAkhilesh Pandey
Akhilesh Pandey
The rapid evolution of mass spectrometry-based single-cell proteomics now enables the cataloging of several thousand proteins from single cells. We investigated whether we could discover cellular heterogeneity beyond proteome, encompassing post-translational modifications (PTM), protein-protein interaction, and variants. By optimizing the mass spectrometry data interpretation strategy to enable the detection of PTMs and variants, we have generated a high-definition dataset of single-cell and nuclear proteomic-states. The data demonstrate the heterogeneity of cell-states and signaling dependencies at the single-cell level and reveal epigenetic drug-induced changes in single nuclei. This approach enables the exploration of previously uncharted single-cell and organellar proteomes revealing molecular characteristics that are inaccessible through RNA profiling.

28 December 2020 in Journal of Oral Pathology & Medicine
Verified
Journal Article
Closed access
PDF file
NBNiraj Babu
Niraj Babu
Shankargouda PatilShankargouda Patil
Shankargouda Patil
SMSonali V. Mohan
Sonali V. Mohan
TSTejaswini Subbannayya
Tejaswini Subbannayya
JAJayshree Advani
Jayshree Advani
ACAditi Chatterjee
Aditi Chatterjee

1 January 2015
Verified
Book Chapter
Closed access
FBFirdous Ahmad Bhat
Firdous Ahmad Bhat
BSBalakrishnan S
Balakrishnan S
AJArunakaran J
Arunakaran J
This chapter examines the importance of nanotechnology in cancer prevention, cure, and diagnosis. This chapter deals with the applications of nanomedicine in cancer and various strategies to target cancer cells by using nanotechnology such as gold nanoparticles, liposomes, nanodots, nanorods, etc. Nanotechnology is an interdisciplinary area with potential applications in fighting many diseases including cancer. Conventional drugs have poor cell specificity, solubility, and high toxicity. The continued development of cancer nanotechnology holds the promise for personalized oncology. For accurate and self-confirming cancer diagnosis, it is essential to combine dual-mode and multi-mode imaging functionalities within one nanoparticle system. Nanoparticles improve the solubility of poorly water-soluble drugs and prolong the half-life of drugs. Disadvantages of nanotechnology include the potential for mass poisoning. Understanding how nano-materials affect live cell functions, controlling such effects, and using them for disease therapeutics are now the principal aims and most challenging aspects of nanobiotechnology and nanomedicine.